Sort   by:  
 Page size 
UnknownDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment.
Not available
S-EPMC4526340 | biostudies-literature
UnknownMolecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo.
Not available
S-EPMC6946859 | biostudies-literature
UnknownAberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
Not available
S-EPMC4422887 | biostudies-literature
UnknownA Virtual Screening Platform Identifies Chloroethylagelastatin A as a Potential Ribosomal Inhibitor.
Not available
S-EPMC7599554 | biostudies-literature
UnknownMacrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK.
Not available
S-EPMC11628987 | biostudies-literature
UnknownImproving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
Not available
S-EPMC11230438 | biostudies-literature
UnknownImproving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
Not available
S-EPMC11429640 | biostudies-literature
UnknownQuantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer.
Not available
S-EPMC7915310 | biostudies-literature
UnknownPomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models.
Not available
S-EPMC3734315 | biostudies-literature
UnknownCytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein.
Not available
S-EPMC5855799 | biostudies-literature
Sort   by:  
 Page size